NHS National Framework for Denosumab Injection commencing 1st January 2026
What the buyer wrote
Project title: NHS National Framework for Denosumab Injection commencing 1st January 2026 Offer reference number: CM/TNS/25/5725 Period of framework: 1 January 2026 to 31 December 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/TNS/25/5725/01 - Regional award for Denosumab Injection: NOFE: (North of England) 01/01/2026 to 31/12/2026 (12 months) SOFE: (South of England) 01/01/2026 to 31/12/2026 (12 months) MAE: (Midlands and East) 01/01/2026 to 31/12/2026 (12 months) LNW: (London) 01/01/2026 to 31/12/2026 (12 months) CM/TNS/25/5725/02 - National award for Denosumab Injection: 7NAT (National) 01/01/2026 to 31/…
Bid for this and lost? There is a short window in which the decision can be questioned.
Details
- What the buyer calls it
- NHS National Framework for Denosumab Injection commencing 1st January 2026
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Lots
- 2
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Work starts
- 1 Jan 2026
- Work ends
- 31 Dec 2026
- Where
- in the North East, in the North West, in the East Midlands, in the West Midlands, in the East of England, in the South East, in the South West, in Yorkshire and The Humber, in London
- Kind of work
- Pharmacy and medicines
Who the buyer named
Russell Greeenwood was the named contact on this notice. Questions closed on 28 Aug 2025, 23:59 BST.